{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:38:38Z","timestamp":1794487118857,"version":"4.9.1"},"reference-count":16,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2020,11,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Malaria is a growing infectious disease burden due to the increasing\nemergence of resistant strains of Plasmodium falciparum. Because of the limited therapeutic efficacy\nof available antimalarial drugs, the development of potent antimalarial drug agents is therefore\nan urgent requirement to fight against resistant malaria.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The objective of this work was to develop novel quinoline-baed antimalarial agents that\nwould be active against resistant P. falciparum malaria.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Some 7-chloro-4-(2-(substituted benzylidene)hydrazineyl)quinolines were synthesized\nfor the evaluation of their potential as possible antimalarial agents, particularly against resistant\nmalaria. The antimalarial activity of synthesized compounds was evaluated in vitro against bloodstage\nparasites of P. falciparum. Further, molecular docking and drug-likeness including ADMET\n(Absorption, Distribution, Metabolism, Elimination and Toxicity) studies were also carried out using\nin silico tools.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Results reveal the in vitro antimalarial activity of synthesized 7-chloro-4-(2-(substituted\nbenzylidene)hydrazineyl)quinolines against P. falciparum. The docking study investigates the antimalarial\neffectiveness of synthesized quinolines as novel plasmepsin 2 inhibitors. Drug-likeness\nprediction exhibits acceptable drug-likeness and ADMET properties.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Based upon our findings, it is concluded that the molecular scaffold of 7-chloro-4-(2-\n(substituted benzylidene)hydrazineyl)quinolines may be used as a lead structure for further modifications\nin the search of more potent antimalarial drug molecules.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406415666190806154722","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T14:45:49Z","timestamp":1565102749000},"page":"928-937","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines"],"prefix":"10.2174","volume":"16","author":[{"given":"Jahnabi","family":"Kalita","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh-786 004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Chetia","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh-786 004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Rudrapal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh-786 004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2017.1363742","author":"Rudrapal M.","year":"2017","unstructured":"Rudrapal M.; Chetia D.; Singh V.; Novel series of 1,2,4-trioxane\n                    derivatives as antimalarial agents. J Enzyme Inhib Med Chem, 32(1), 1159-11732017","journal-title":"J Enzyme Inhib Med Chem,"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.2147\/DDDT.S118116","volume":"10","author":"Rudrapal M.","year":"2016","unstructured":"Rudrapal M.; Chetia D.; Endoperoxide antimalarials: development,\n                    structural diversity and pharmacodynamic aspects with reference to\n                    1,2,4-trioxane-based structural scaffold 2016,10,3575-3590"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1016\/j.bmcl.2012.07.028","volume":"22","author":"Sashidhara K.V.","year":"2012","unstructured":"Sashidhara K.V.; Avula S.R.; Palnati G.R.; Singh S.V.; Srivastava K.; Puri S.K.; Saxena J.K.;  Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum  Bioorg Med Chem Lett 2012,22(17),5455-5459","journal-title":"Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum  Bioorg Med Chem Lett"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1016\/j.bmc.2009.06.051","volume":"17","author":"Gemma S.","year":"2009","unstructured":"Gemma S.; Savini L.; Altarelli M.; Tripaldi P.; Chiasserini L.; Coccone S.S.; Kumar V.; Camodeca C.; Campiani G.; Novellino E.; Clarizio S.; Delogu G.; Butini S.; Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies. Bioorg. Med. Chem. 2009,17(16),6063-6072"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00044-017-2090-8","volume":"27","author":"Rudrapal M.","year":"2018","unstructured":"Rudrapal M.; Banu Z.W.; Chetia D.;  Newer series of trioxane derivatives as potent antimalarial agents  Med Chem Res 2018,27,668-6072","journal-title":"Newer series of trioxane derivatives as potent antimalarial agents  Med Chem Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0022-2836(03)00036-6","volume":"203","author":"Asojo O.A.","year":"2003","unstructured":"Asojo O.A.; Gulnik S.V.; Afonina E.; Yu B.; Ellman J.A.; Haque T.S.; Silva A.M.;  Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum. J. Mol. Biol 2003,203(1),173-181"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1016\/j.bmcl.2012.04.100","volume":"22","author":"Sashidhara K.V.","year":"2012","unstructured":"Sashidhara K.V.; Kumar A.; Dodda R.P.; Krishna N.N.; Agarwal P.; Srivastava K.; Puri S.K.;  Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds Bioorg Med Chem Lett 2012,22(12),3926-3930","journal-title":"Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds Bioorg Med Chem Lett"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejmech.2016.09.050","volume":"125","author":"Franchini S.","year":"2017","unstructured":"Franchini S.; Manasieva L.I.; Sorbi C.; Battisti U.M.; Fossa P.; Cichero E.; Denora N.; Iacobazzi R.M.; Cilia A.; Pirona L.; Ronsisvalle S.; Aric\u00f2 G.; Brasili L.; Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4- dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists. Eur. J. Med. Chem., 2017,125,435-452"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2016.01.059","volume":"112","author":"Franchini S.","year":"2016","unstructured":"Franchini S.; Battisti U.M.; Prandi A.; Tait A.; Borsari C.; Cichero E.; Fossa P.; Cilia A.; Prezzavento O.; Ronsisvalle S.; Aric\u00f2 G.; Parenti C.; Brasili L.; Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives. Eur. J. Med. Chem 2016,112,1-9"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1039\/C5MD00490J","volume":"7","author":"Cichero E.","year":"2016","unstructured":"Cichero E.; Espinoza S.; Tonelli M.; Franchini S.; Gerasimov A.S.; Sorbi C.; Gainetdinov R.R.; Brasili L.; Fossa P.; A homology modeling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists. MedChemComm, 2016,7,353-364"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.;  2001,46(1-3),3-26"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1549","author":"Kitchen D.B.","year":"2004","unstructured":"Kitchen D.B.; Decornez H.; Furr J.R.; Bajorath J.; Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3(11), 935-949.2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref=13","first-page":"53","volume":"29","author":"Patowary P.","year":"2019","unstructured":"Patowary P.; Chetia D.; Kalita J.; Rudrapal M.; Design, Synthesis and antimalarial activity of flavonoid derivatives. Indian J Heterocycl Chem 2019,29,53-58","journal-title":"Indian J Heterocycl Chem"},{"key":"ref=14","author":"Roviello G.N.","year":"2018","unstructured":"Roviello G.N.; Novel insights into nucleoamino acids: biomolecular recognition and aggregation studies of a thymine-conjugated Lphenyl alanine. Amino Acids  50(7), 933-9412018","journal-title":"Amino Acids"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-009-0361-5","author":"Roviello G.N.","year":"2010","unstructured":"Roviello G.N.; Di Gaetano S.; Capasso D.; Cesarani A.; Bucci E.M.; Pedone C.; Synthesis, spectroscopic studies and biological activity of a novel nucleopeptide with Moloney murine leukemia virus reverse transcriptase inhibitory activity. Amino Acids 38(5), 1489-1496.2010","journal-title":"Amino Acids"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.09.153","author":"Carella A.","year":"2019","unstructured":"Carella A.; Roviello V.; Iannitti R.; Palumbo R.; La Manna S.; Marasco D.; Trifuoggi M.; Diana R.; Roviello G.N.; Evaluating\nthe biological properties of synthetic 4-nitrophenyl functionalized\nbenzofuran derivatives with telomeric DNA binding and antiproliferative activities Int J Biol Macromol 121, 77-882019","journal-title":"Int J Biol Macromol"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/174128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/174128\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/174128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:29:39Z","timestamp":1621538979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/174128\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,11,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406415666190806154722","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}